Who are the market's top vendors, and What are Their Offerings?
| Tier 1 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Zoetis | Parsippany, New Jersey | USA | Largest pure-play animal health company with strong livestock and companion animal presence across MEA | Vaccines, parasiticides, diagnostics, livestock health solutions |
| MSD Animal Health | Rahway, New Jersey | USA | Major vaccine and livestock disease management provider throughout MEA | Vaccines, animal identification, monitoring technologies |
| Boehringer Ingelheim Animal Health | Ingelheim am Rhein | Germany | Strong vaccine and parasiticide portfolio with extensive regional partnerships | Vaccines, antiparasitics, companion animal therapeutics |
| Tier 2 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Virbac | Carros | France | Significant veterinary pharmaceutical and companion animal presence | Vaccines, dermatology, parasiticides |
| HIPRA | Amer, Girona | Spain | Strong vaccine specialization and expanding international footprint | Livestock and poultry vaccines |
| Vetoquinol | Lure | France | Established veterinary medicine provider with global reach | Companion and livestock therapeutics |
| Tier 3 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Biovac | Cape Town, Western Cape | South Africa | Important African vaccine manufacturing capability | Veterinary and biological manufacturing expertise |
| Hester Biosciences | Ahmedabad, Gujarat | India | Active supplier of animal vaccines in emerging markets including Africa | Poultry and livestock vaccines |
What are the Major Recent Developments in the Market?
- In May 2026, the country’s first private veterinary teaching hospital and college under a new project at Thumbay Medicity was launched by Thumbay Group in the UAE in Ajman. This project will offer advanced veterinary care, future farm-based learning facilities, and academic training.
- In February 2026, a memorandum of understanding was signed between Saudi authorities and France’s Ceva Santé Animale under the sponsorship of Abdulrahman bin Abdulmohsen Al-Fadhli, Minister of Environment, Water, and Agriculture, and chairman of the National Livestock and Fisheries Development Program. This partnership aims at transforming veterinary care in Saudi Arabia by focusing on local vaccine production for livestock and poultry.
Market Value Chain Analysis
R&D
- The R&D of the Middle East and Africa animal health focuses on the development of vaccines, specialized therapies, and diagnostics.
- Key players: Zoetis Inc., Boehringer Ingelheim Animal Health, MSD Animal Health.
Clinical Trials and Regulatory Approvals
- Vaccine efficacy, heat stability, target animal safety, and strict withdrawal period are evaluated in the clinical trials and regulatory approvals of animal health in the Middle East and Africa.
- Key players: Zoetis Inc., Boehringer Ingelheim Animal Health, MSD Animal Health.
Patient Support and Services
- Localized mobile veterinary consulting vans, multilingual technical training clinics, SMS-based disease alert systems, and digital vaccination tracking apps are provided in the patient support and services of the Middle East and Africa animal health.
- Key players: Zoetis Inc., Boehringer Ingelheim Animal Health, MSD Animal Health.
Market Growth
The Middle East and Africa animal health market size was estimated at USD 5.48 billion in 2025 and is predicted to increase from USD 5.96 billion in 2026 to approximately USD 12.67 billion by 2035, expanding at a CAGR of 8.74% from 2026 to 2035.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking